0002104165-26-000002.txt : 20260107 0002104165-26-000002.hdr.sgml : 20260107 20260107162713 ACCESSION NUMBER: 0002104165-26-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260107 DATE AS OF CHANGE: 20260107 EFFECTIVENESS DATE: 20260107 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Matthias Therapeutics, LLC CENTRAL INDEX KEY: 0002104165 ORGANIZATION NAME: EIN: 931996222 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-569234 FILM NUMBER: 26516002 BUSINESS ADDRESS: STREET 1: 27 SENTINEL DRIVE CITY: BASKING RIDGE STATE: NJ ZIP: 07920 BUSINESS PHONE: 2016850842 MAIL ADDRESS: STREET 1: 27 SENTINEL DRIVE CITY: BASKING RIDGE STATE: NJ ZIP: 07920 D 1 primary_doc.xml X0708 D LIVE 0002104165 Matthias Therapeutics, LLC 27 SENTINEL DRIVE BASKING RIDGE NJ NEW JERSEY 07920 2016850842 DELAWARE None None Limited Liability Company true 2023 Matthew Redling 27 SENTINEL DRIVE BASKING RIDGE NJ NEW JERSEY 07920 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2025-11-24 false true true false 50000 TerraNova Capital Equities, Inc. 45097 None None 420 LEXINGTON AVENUE SUITE 1402 NEW YORK NY NEW YORK 10170 HI HAWAII TX TEXAS FL FLORIDA WA WASHINGTON NY NEW YORK SC SOUTH CAROLINA WI WISCONSIN MA MASSACHUSETTS MD MARYLAND OH OHIO GA GEORGIA ID IDAHO MI MICHIGAN CA CALIFORNIA UT UTAH MN MINNESOTA MO MISSOURI IL ILLINOIS OR OREGON IN INDIANA MS MISSISSIPPI MT MONTANA KS KANSAS AK ALASKA AL ALABAMA VA VIRGINIA CO COLORADO KY KENTUCKY AR ARKANSAS CT CONNECTICUT PA PENNSYLVANIA LA LOUISIANA NC NORTH CAROLINA AZ ARIZONA NH NEW HAMPSHIRE NJ NEW JERSEY VT VERMONT DC DISTRICT OF COLUMBIA NM NEW MEXICO false 500000 100000 400000 false 2 10000 true 0 true 0 true false Matthias Therapeutics, LLC /s/ Matthew Redling Matthew Redling Chief Executive Officer 2026-01-07